Cargando…

In Reply — COVID-19, the Female Immune Advantage, and Cardiovascular Impact

Detalles Bibliográficos
Autores principales:	Ritter, Oliver, Kararigas, Georgios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952147/ https://www.ncbi.nlm.nih.gov/pubmed/33673934 http://dx.doi.org/10.1016/j.mayocp.2020.12.020

Ejemplares similares

COVID-19, the Female Immune Advantage, and Cardiovascular Impact
por: Gersh, Felice L., et al.
Publicado: (2021)

Sex-Biased Vulnerability of the Heart to COVID-19
por: Ritter, Oliver, et al.
Publicado: (2020)

Reply to “Impact of COVID-19 on the mental health of radiologists”
por: Demirjian, Natalie L., et al.
Publicado: (2021)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to: Dilemmas in Immunization?
por: Abedi, Ali J
Publicado: (2013)

REPLY BY THE AUTHORS: RE: Impact of COVID-19 on a urology residency program
por: Danilovic, Alexandre, et al.
Publicado: (2021)

Reply to: The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
por: Cosentino, Nicola, et al.
Publicado: (2023)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Reply: Prostate Cancer and Cardiovascular Risk Factors
por: Klimis, Harry, et al.
Publicado: (2023)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

Author`s Reply
por: Manolis, Antonis S., et al.
Publicado: (2018)

Author`s Reply
por: Manolis, Antonis S., et al.
Publicado: (2018)

In Reply — Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization
por: Lavie, Carl J., et al.
Publicado: (2021)

In Reply to the Letter to the Editor Regarding “Impact of COVID-19 on Neurosurgical Training in Southeast Asia”
por: Baticulon, Ronnie E., et al.
Publicado: (2021)

Authors’ reply to a commentary on the potential impact of COVID-19 passports to epidemiological situation
por: Stankūnas, Mindaugas, et al.
Publicado: (2023)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply to “Pulmonary toxicity by oxygen and COVID-19”()
por: Belenguer-Muncharaz, A., et al.
Publicado: (2022)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Research in Neurosurgery: An Advantage of COVID Pandemic
por: Dahal, Alok, et al.
Publicado: (2022)

Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO?
por: Bleakley, Caroline, et al.
Publicado: (2021)

Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”
por: Praktiknjo, Michael, et al.
Publicado: (2021)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

In reply—COVID-19: Precision Medicine and Vascular Endothelium
por: Cresci, Sharon, et al.
Publicado: (2021)

Reply to professionally responsible COVID-19 vaccination counseling
por: Chervenak, Frank A., et al.
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

In Reply to the Letter to the Editor Regarding “Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience”
por: Khalafallah, Adham M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pdgbvcl6vc5vs905vf2a4t9lrj